| Tretinoin | Approved Investigational Nutraceutical | CDKN2B | 1030 |
upregulated | Tretinoin results in increased expression of CDKN2B mRNA | 9p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN2C | 1031 |
upregulated | Tretinoin results in increased expression of CDKN2C mRNA | 1p32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN2D | 1032 |
upregulated | Tretinoin results in increased expression of CDKN2D mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDKN3 | 1033 |
downregulated | Tretinoin results in decreased expression of CDKN3 mRNA | 14q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDON | 50937 |
downregulated | Tretinoin results in decreased expression of CDON mRNA | 11q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDS1 | 1040 |
upregulated | Tretinoin results in increased expression of CDS1 mRNA | 4q21.23 | |
| Tretinoin | Approved Investigational Nutraceutical | CDT1 | 81620 |
downregulated | Tretinoin results in decreased expression of CDT1 mRNA | 16q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CEACAM1 | 634 |
upregulated | Tretinoin results in increased expression of CEACAM1 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CEACAM6 | 4680 |
upregulated | Tretinoin results in increased expression of CEACAM6 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CEACAM7 | 1087 |
upregulated | Tretinoin results in increased expression of CEACAM7 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CEBPB | 1051 |
upregulated | Tretinoin results in increased expression of CEBPB mRNA | 20q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CEBPD | 1052 |
downregulated | Tretinoin results in decreased expression of CEBPD mRNA | 8q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | CEBPD | 1052 |
upregulated | Tretinoin results in increased expression of CEBPD mRNA | 8q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | CEBPE | 1053 |
upregulated | Tretinoin results in increased expression of CEBPE mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CEBPG | 1054 |
downregulated | Tretinoin results in decreased expression of CEBPG mRNA | 19q13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | CEBPZ | 10153 |
downregulated | Tretinoin results in decreased expression of CEBPZ mRNA | 2p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CEBPZ | 10153 |
upregulated | Tretinoin results in increased expression of CEBPZ mRNA | 2p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CELF1 | 10658 |
downregulated | Tretinoin results in decreased expression of CELF1 mRNA | 11p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CELF2 | 10659 |
downregulated | Tretinoin results in decreased expression of CELF2 mRNA | 10p14 | |
| Tretinoin | Approved Investigational Nutraceutical | CELF5 | 60680 |
downregulated | Tretinoin results in decreased expression of CELF5 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CELSR1 | 9620 |
upregulated | Tretinoin results in increased expression of CELSR1 mRNA | 22q13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CELSR3 | 1951 |
downregulated | Tretinoin results in decreased expression of CELSR3 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CEND1 | 51286 |
upregulated | Tretinoin results in increased expression of CEND1 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | CENPH | 64946 |
downregulated | Tretinoin results in decreased expression of CENPH mRNA | 5q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CENPP | 401541 |
downregulated | Tretinoin results in decreased expression of CENPP mRNA | 9q22.31 | |